Literature DB >> 12403370

Immunobiology of tumor necrosis factor receptor superfamily.

Tong Zhou1, John D Mountz, Robert P Kimberly.   

Abstract

The proteins of the tumor necrosis factor (TNF) receptor superfamily are a group of cell-surface receptors critically involved in the maintenance of homeostasis of the immune system. By interacting with their corresponding ligands, these receptors either induce cell death or promote cell survival of immune cells. The number of recognized members of the TNF receptor and ligand superfamily has expanded substantially in the last several years. More important, the biologic function of this group of proteins has been closely associated with the regulation of the immune response and the pathogenesis of autoimmune disease. Thus, the direct targeting of these receptors by either inducing apoptosis or blocking survival of autoimmune T and B cells may be an important therapeutic strategy in the treatment of autoimmune disease. This review summarizes the recent progress in immunobiology of the TNF receptor superfamily and focuses on our studies of three critical family members-FasL/Fas, TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL-Rs, and B lymphocyte stimulator(BLyS)/BLyS-Rs--to demonstrate the therapeutic potential of targeting these receptors for the treatment of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403370     DOI: 10.1385/IR:26:1-3:323

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  74 in total

1.  LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

Authors:  K Tamada; K Shimozaki; A I Chapoval; Y Zhai; J Su; S F Chen; S L Hsieh; S Nagata; J Ni; L Chen
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.

Authors:  S Xu; K P Lam
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 3.  The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease.

Authors:  F H Durie; T M Foy; R J Noelle
Journal:  Res Immunol       Date:  1994 Mar-Apr

4.  Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.

Authors:  R B Shaikh; S Santee; S W Granger; K Butrovich; T Cheung; M Kronenberg; H Cheroutre; C F Ware
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

5.  A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity.

Authors:  K Ichikawa; H Yoshida-Kato; M Ohtsuki; J Ohsumi; J Yamaguchi; S Takahashi; Y Tani; M Watanabe; A Shiraishi; K Nishioka; S Yonehara; N Serizawa
Journal:  Int Immunol       Date:  2000-04       Impact factor: 4.823

6.  TALL-1 is a novel member of the TNF family that is down-regulated by mitogens.

Authors:  H B Shu; W H Hu; H Johnson
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

7.  The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.

Authors:  I A Rooney; K D Butrovich; A A Glass; S Borboroglu; C A Benedict; J C Whitbeck; G H Cohen; R J Eisenberg; C F Ware
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

8.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

9.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  15 in total

1.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

2.  The SCHOOL of nature: II. Protein order, disorder and oligomericity in transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-02-22

3.  CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis.

Authors:  Zhongyu Liu; Xin Xu; Hui-Chen Hsu; Albert Tousson; Ping-Ar Yang; Qi Wu; Cunren Liu; Shaohua Yu; Huang-Ge Zhang; John D Mountz
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

4.  Fas mediates cardiac allograft acceptance in mice with impaired T-cell-intrinsic NF-kappaB signaling.

Authors:  Luciana Lorena Molinero; Ying Wang; Ping Zhou; Hideo Yagita; Maria-Luisa Alegre
Journal:  Transpl Int       Date:  2009-04-01       Impact factor: 3.782

Review 5.  TNF-α signalling and inflammation: interactions between old acquaintances.

Authors:  Hana Zelová; Jan Hošek
Journal:  Inflamm Res       Date:  2013-05-18       Impact factor: 4.575

6.  Effects of lipopolysaccharide on the response of C57BL/6J mice to whole thorax irradiation.

Authors:  Asif Zaidi; Salomeh Jelveh; Javed Mahmood; Richard P Hill
Journal:  Radiother Oncol       Date:  2012-09-14       Impact factor: 6.280

Review 7.  The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors:  Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.

Authors:  Vinh Nguyen; Cornelia Cudrici; Valentina Zernetkina; Florin Niculescu; Horea Rus; Cynthia Drachenberg; Violeta Rus
Journal:  Clin Immunol       Date:  2009-04-05       Impact factor: 3.969

9.  The safety of etanercept for the treatment of plaque psoriasis.

Authors:  Kim A Papp
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

10.  Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.

Authors:  Yang Liu; Phong Quang; Esteban Braggio; Hai Ngo; Gayane Badalian-Very; Ludmila Flores; Yong Zhang; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Feda Azab; Ruben Carrasco; Barrett J Rollins; Aldo M Roccaro; Irene M Ghobrial
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.